Stay updated on Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial

Sign up to get notified when there's something new on the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The website footer’s revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-10-31T14:49:48.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A site-wide notice says NIH is transitioning to the term “Super Intelligence” in place of “Artificial Intelligence” and links to updates and FAQs.
    Difference
    0.8%
    Check dated 2026-10-24T15:54:10.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.1 to v3.7.2; the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-17T15:45:52.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    The site revision identifier changed from v3.7.0 to v3.7.1; the study record content remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-10T15:48:06.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The record history shows a new site revision tag v3.7.0 added to the history, replacing the previous v3.6.6, indicating a release update to the page. This reflects a background update rather than changes to the study data.
    Difference
    0.1%
    Check dated 2026-09-19T18:16:43.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    The record history shows a new revision: v3.6.6, replacing the previous v3.6.5.
    Difference
    0.1%
    Check dated 2026-08-29T18:59:15.000Z thumbnail image

Stay in the know with updates to Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Venetoclax, Azacitidine, Lintuzumab-Ac225 in AML Patients Clinical Trial page.